Jie Chen

Lequn Li, Jie Chen, Xiao-bo Wang, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Marsdenia tenacissima injection induces the apoptosis of prostate cancer by regulating the AKT/GSK3β/STAT3 signaling axis.

Hongwei Guo, Zhiheng Su, Jie Chen, 2023, Chinese journal of natural medicines.

Efficacy of hepatic resection for huge (≥ 10 cm) hepatocellular carcinoma: good prognosis associated with the uninodular subtype.

Lequn Li, J. Zhong, Jie Chen, 2015, International journal of clinical and experimental medicine.

Factors associated with postoperative HBV reactivation in HBV related hepatocellular carcinoma patients with HBV-DNA levels less than the minimum

Lequn Li, Jie Chen, T. Bai, 2016 .

Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma

Tao Luo, Lequn Li, Jie Chen, 2019, Medical science monitor : international medical journal of experimental and clinical research.

Systematic review comparing the safety and efficacy of conventional and drug‐eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma

Lequn Li, J. Zhong, W. Gong, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors

Bowen Liu, Lequn Li, Jie Chen, 2023, Frontiers in Oncology.

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

Lequn Li, Jie Chen, T. Bai, 2017, BMC Cancer.

Decreased Expression of Long Non-Coding RNA GMDS Divergent Transcript (GMDS-DT) is a Potential Biomarker for Poor Prognosis of Hepatocellular Carcinoma

Junjie Liu, Lequn Li, Jie Chen, 2019, Medical science monitor : international medical journal of experimental and clinical research.

Downregulation of Macrophage-Derived T-UCR uc.306 Associates with Poor Prognosis in Hepatocellular Carcinoma

Tao Luo, Lequn Li, Jie Chen, 2017, Cellular Physiology and Biochemistry.

Serum Immune Biomarker Levels combined with Hepatitis B Virus Infection Status Predicts Early Recurrence of Early-Stage Hepatocellular Carcinoma with Microvascular Invasion after Liver Resection.

Lequn Li, Jie Chen, T. Bai, 2022, Acta chirurgica Belgica.

Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma

Lequn Li, Zhiwei Chen, Jie Chen, 2020, Translational cancer research.

Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.

Lequn Li, Jie Chen, T. Bai, 2016, World journal of gastroenterology.

The correlations between hepatitis B virus infection and hepatocellular carcinoma with portal vein tumor thrombus or extrahepatic metastasis

Tao Luo, Lequn Li, Jie Chen, 2020, European journal of gastroenterology & hepatology.

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients

Lequn Li, Guo-Bin Wu, Jie Chen, 2019, Cancer management and research.

Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma

Lequn Li, Guo-Bin Wu, Jie Chen, 2019, Cancer management and research.

CMAR_A_213432 8799..8806

Lequn Li, Guo-Bin Wu, Jie Chen, 2019 .

A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population

Lequn Li, N. Peng, Jie Chen, 2012, Molecular Biology Reports.

Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update

Lequn Li, Jie Chen, T. Bai, 2017, Oncotarget.

Consistency analysis of contrast-enhanced ultrasound and contrast-enhanced CT in diagnosis of small hepatocellular carcinoma.

Lequn Li, Jie Chen, T. Bai, 2015, International Journal of Clinical and Experimental Medicine.

Developmental artificial neural network model to evaluate the preoperative safe limit of future liver remnant volume for HCC combined with clinically significant portal hypertension.

Lequn Li, Wei-xing Guo, Jie Chen, 2022, Future oncology.

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension

Zhi-Yuan Zhang, Lequn Li, J. Zhong, 2014, PloS one.

Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.

Chang Zhao, Tao Luo, Lequn Li, 2023, Heliyon.

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus

Jie Chen, T. Bai, Shaoliang Zhu, 2016, OncoTargets and therapy.

Oncotargets and Therapy Dovepress the Efficacy and Safety of Postoperative Adjuvant Transarterial Embolization and Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Jun-jie Liu 2,4

Lequn Li, Jie Chen, T. Bai, 2022 .

Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma

Lequn Li, Jie Chen, Yu Zhang, 2016, OncoTargets and therapy.

Original Article The safety and efficacy of laparoscopic and open hepatectomy in hepatocellular carcinoma patients with liver cirrhosis: a systematic review

Lequn Li, Jie Chen, T. Bai, 2015 .

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

Lequn Li, Jie Chen, T. Bai, 2017, BMC Cancer.

Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma

Tao Luo, Junjie Liu, Lequn Li, 2019, OncoTargets and therapy.

Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma

Tao Luo, Junjie Liu, Lequn Li, 2019, OncoTargets and therapy.

Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study.

Shao-long Lu, Jie Chen, T. Bai, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study

Jie Chen, Xiaobo Wang, Lequn Li, 2024, BMC cancer.

Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study

Jie Chen, Xiao-bo Wang, Jianfang Ye, 2024, Langenbeck's archives of surgery.